CoChat

Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study

Hommell-Fontaine, J., Isaac, S., Passot, G., Decullier, E., Traverse-Glehen, A., Cotte, E., You, B., Mohamed, F., Gilly, F. N., Glehen, O., Berger, F. · 2013 · Annals of Surgical Oncology

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Purpose Diffuse malignant peritoneal mesothelioma (DMPM) is a rare primary peritoneal malignancy. Its prognosis has been improved by an aggressive locoregional treatment combining extensive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Prognostic factors are currently poorly defined for this disease but are essential if treatment is to be standardized.Methods Twenty-eight patients with DMPM, who were considered preoperatively to be candidates for CRS and HIPEC between June 1998 and August 2010 at our institution, were selected for this study. Medical records and histopathological features were retrospectively reviewed and 24 clinical, histological, and immunohistochemical parameters were assessed for their association with overall survival by univariate and multivariate analyses.Results The following factors were significantly associated with overall survival by univariate analysis: predominant histological growth pattern in the epithelioid areas, nuclear grooves in the epithelioid areas, atypical mitoses, and calretinin and GLUT1 expression by immunohistochemistry in the epithelioid areas. Expression of the facilitative glucose transporter protein GLUT1 in the epithelioid areas was the only factor independently associated with overall survival by multivariate analysis.Conclusions GLUT1 expression appears to be an indicator of poor prognosis in DMPM. Standard histological classification of DMPM may not be adequate to select patients for aggressive locoregional treatments, such as CRS and HIPEC. Multicenter validation of the prognostic factors identified in this preliminary study is needed to refine patient selection for potential cure.

Overview

Integrity signals

Registry

Crossref · 10.1245/s10434-013-3077-4

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 51 references

Research works printed but not linked: 1

  1. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. World Health Organization Classification of Tumors: pathology and genetics of tumors of the lung, pleura, thymus and heart. 3rd ed. Lyon: IARC Press; 2004.

Cited by

See all 23

Metadata

Authors
Hommell-Fontaine, J., Isaac, S., Passot, G., Decullier, E., Traverse-Glehen, A., Cotte, E., You, B., Mohamed, F., Gilly, F. N., Glehen, O., & Berger, F.
Affiliations
  • Hospices Civils de Lyon (FR)
  • Lyon 1 Université (FR)
  • Basingstoke and North Hampshire Hospital (GB)
Venue
Annals of Surgical Oncology
Published
2013-06-26
Volume
20
Issue
12
Pages
3892-3898
ISSN
  • 1068-9265 (ISSN-L)
  • 1534-4681
OpenAlex
W2094770704
Cited by
23
References
51
Citations by year
2026: 1 · 2023: 2 · 2022: 2 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 6 · 2016: 2 · 2014: 2
FWCI
1.31
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Annals of Surgical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
Keywords
diffuse malignant peritoneal mesothelioma, GLUT1 expression, prognostic factors, overall survival, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, calretinin, atypical mitoses, patient selection
MeSH terms
Mesothelioma, Malignant, Antineoplastic Combined Chemotherapy Protocols, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Hyperthermia, Induced, Immunoenzyme Techniques, Lung Neoplasms, Male, Mesothelioma, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Chemotherapy, Cancer, Regional Perfusion, Peritoneal Neoplasms, Prognosis, Retrospective Studies, Biomarkers, Tumor, Survival Rate, Tissue Array Analysis, Glucose Transporter Type 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study. https://app.cochat.ai/papers/10.1245/s10434-013-3077-4
The paper
Hommell-Fontaine, J., Isaac, S., Passot, G., Decullier, E., Traverse-Glehen, A., Cotte, E., You, B., Mohamed, F., Gilly, F. N., Glehen, O., & Berger, F. (2013). Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-013-3077-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.